Cytodyn Inc (CYDY)

[Venture_Cap]

Can’t divulge that but I think it’s not going anywhere with NP at the helm. Let’s just say I’m in the business and obviously HAART is heavily invested in. LL poses a clear and present danger to billions of leveraged research. This we know. These conversations are ongoing with our BOD connections, it’s been ongoing since 2018. NP likes to name drop to keep the SP up, but I think it’s heating up as the LL cat peeks out of the bag.

A buyout doesn’t make sense anyway due to LL multi indications. It needs to be licensed appropriately for the indications. Doesn’t make sense for one BP to own the multi indications and it hints at anti-trust investigations. Cancer, HIV, NASH, ARDS, vaccines... etc... I know medical professionals that are saying this could be revolutionary medicine. Add in those already on YouTube and I’m surprised it’s not getting eaten up like candy at these prices.

It is nice to see the likes of BP realize that Covid is potentially providing funding to a market disruptor and time is running out on snuffing it or getting exclusivity rights.

There are other CCR5 blockers in BP inventory but none have the safety of LL and that’s important in sick cancer, HIV patients.

You likely know this already.

My prediction is no buyout but multiple licensing agreements with 2-3 BPs.